Catalog Advanced Search

Search by Category
Search by Format
Sort By
Search by Type
Search by Keyword
Search by Category
Search in Packages
Search by Format
Search by Type
Search by Date Range
Products are filtered by different dates, depending on the combination of live and on-demand components that they contain, and on whether any live components are over or not.
Start
End
Search by Keyword
Sort By
  • Contains 4 Component(s), Includes Credits Includes a Live Web Event on 02/15/2023 at 12:00 PM (EST)

    This presentation will provide information about the unique patient/home infusion clinician relationship which can have inherent pitfalls with regards to maintaining professional boundaries.

    This presentation will provide information about the unique patient/home infusion clinician relationship which can have inherent pitfalls with regards to maintaining professional boundaries. Patients who are receiving home infusion therapy are often on service for months to years, many times with the same primary clinicians.  This presentation will examine what a professional boundary is, how to discern if the boundary is being crossed, and how to resolve any boundary issues during the therapeutic relationship.

    Learning Objectives:

    1. Understand the definition of practice guidelines for professional boundaries.
    2. Describe the tenets of a therapeutic professional relationship.
    3. Identify signs that boundaries between the clinician and the patient are crossed.
    4. Discuss strategies for maintaining clear and appropriate boundaries. 

    Lou Anne Epperson

    Director of Clinical Services - Nursing

    Amerita

    Lou Anne Epperson, MSN, RN, IgCN, is the Director of Clinical Services - Nursing, for Ameria Specialty Infusion Services. Lou Anne is a member of INS and is an Advisory Board Member of IgNS.

    Lou Anne received her Masters of Science in Nursing with Administrative focus, and has been involved with nursing education and home infusion for over 30 years. She has presented to local and national audiences regarding home care, home infusion of Ig, nursing competency and education.  She has also published articles in peer-reviewed journals related to home infusion therapy. nutrition and nursing competency.

    No Disclosures to Report

  • Contains 2 Component(s)

    NHIA’s Connie Sullivan and Bill Noyes will focus on recent rules and regulations that members need to be aware to incorporate into their operational plans, billing and coding procedures, and advocacy efforts.

    NHIA’s Connie Sullivan and Bill Noyes will focus on recent rules and regulations that members need to be aware of to incorporate into their operational plans, billing and coding procedures, and advocacy efforts.

    Pertinent topics will include:

    • 2023 Medicare rate adjustments for various provider/supplier types
    • Administrative simplification – Medicare is eliminating the DIF for IV/PEN items
    • Medical unlikely edits (MUE) updates – Hizentra and PN lipids
    • Use of the new JZ modifier
    • Public Health Emergency (PHE) – timing and how it effects COVID-19 monoclonal coverage
    • Inflation Reduction Act effects on Part D POO costs in 2024

    NHIA will recap recent private payor advocacy efforts, including takeaways from its first Payor Summit and efforts to Modernize the HCPCS code set.

    We will also cover the latest updates to the Preserving Patient Access to Home Infusion Act.

    Talk Infusion 2022 Webinar Series Sponsored by McKesson.

    Connie Sullivan

    President & CEO

    National Home Infusion Association

    Connie Sullivan, BSPharm, is the President and CEO of NHIA. Prior to joining the NHIA staff, Sullivan was a practicing home infusion pharmacist and National Infusion Director for HCR ManorCare for 15 years. She is the Vice Chair of USP’s Sterile Compounding Expert Committee and USP’s Parenteral Nutrition Safety Expert Panel.

    No Disclosures to Report

    Bill Noyes

    Sr VP of Reimbursement Policy

    NHIA

    Bill Noyes is the Senior Vice President of Reimbursement Policy at the National Home Infusion Association (NHIA). He joined NHIA in 2012 as Vice President of Health Information Policy, focusing on reimbursement and regulatory issues affecting providers' ability to do business and collect payment for their services. Noyes sits on four Medicare Contractor Advisory Councils and is the liaison to NHIA's reimbursement-focused committees. He also works closely with the NHIA government relations team to gain more meaningful Medicare coverage for home infusion. He served as Interim CEO of the associaiton from July 2018 to November 2018. Prior to joining NHIA, Noyes spent 20 years as Vice President of Operations for a multi-state home infusion provider where he was responsible for purchasing, distribution, facilities, revenue cycle management, and pharmacy operations.

    No Disclosures to Report

    Shea McCarthy

    Director of Legislative Affairs

    NHIA

    As a respected lobbyist and health policy analyst representing some of Washington’s most influential stakeholders, Shea McCarthy serves as NHIA's Director of Legislative Affairs as well as a full time consultant.  As a Senior Vice President at the firm Thorn Run Partners, Mr. McCarthy advises clients on the intricacies of health care policy, develops sophisticated government relations strategies, and has successfully influenced federal laws. By offering a deeply coordinated approach to advocacy — combining facets of technology, grassroots engagement, PR, and traditional lobbying — Mr. McCarthy and his team of experts actively position stakeholders for success. 

    His experience has also been leveraged in the political arena, where he's worked on the Digital Events team for Mitt Romney’s Presidential campaign. Before to joining Thorn Run, Mr. McCarthy worked on in the office of Sen. Cory Gardner (R-CO). He is widely regarded as a thought leader in the health policy field, and his analysis has been featured in leading national and inside-the-Beltway publications such as Business Insider, STAT News, Inside Health Policy, Modern Healthcare, Morning Consult, and RealClearHealth.

    He received his Bachelor's degree from the University of Notre Dame.

    No Disclosures to Report

  • Contains 4 Component(s), Includes Credits

    On Novemeber 1, 2022 USP released the revised version of General Chapter Pharmaceutical Compounding--Sterile Preparations, which becomes enforceable November 1, 2023.

    On Novemeber 1, 2022 USP released the revised version of General Chapter <797> Pharmaceutical Compounding--Sterile Preparations, which becomes enforceable November 1, 2023. Although revisions were proposed (and subsequently appealed) in previous years, this version will represent a significant change from the 2008 standards which are currently enforceable. Home infusion pharmacies will need to comprehend how the updated standards apply to their sterile compounding operations. This article will cover the significant areas, including: beyond-use dating for categories 1, 2, and 3 CSPs, requirements for clean room personnel qualification and evaluation, the need for a designated person(s) to ensure the sterile environment maintains quality, environmental monitoring changes and the need for increased testing and cleaning.

    Learning Objectives:

    1. Review the latest updates to USP General Chapter <797> compared to the 2008 version which remains enforceable until November 1, 2023. 
    2. Understand the difference between Category 1, 2, and 3 compounded sterile preparations (CSPs) and list the specific requirements for each.
    3. Describe the requirements for personnel qualification and evaluation.
    4. Explain the increased frequencies for environmental monitoring and cleaning.

    Abby Roth, BS, CMQ/OE

    Founder

    Pure Microbiology

    Abby Roth, founder of Pure Microbiology, has over 18 years of experience in supporting the testing and consulting needs of the pharmaceutical, medical device, and compounding industries. Her background in pharmaceutical microbiology includes extensive knowledge of environmental monitoring. Abby served as a USP Compounding EC member during the 2015-2020 cycle. She is an involved member of the Controlled Environment Testing Association (CETA), serving on the Board of Directors, speaking at its annual meetings, and chairing committees for the revision of four CETA Application Guides. Abby has been invited to speak for state boards of pharmacy and for national organizations.

    No Disclosures to Report

  • Contains 2 Component(s) Recorded On: 11/15/2022

    As staffing shortages continue, clinical teams must adopt new strategies to support and care for their patients.

    As staffing shortages continue, clinical teams must adopt new strategies to support and care for their patients. In this webinar, explore technology optimizations that drive access to data, ease of documentation, and collaborative communication. Join a veteran home infusion nurse and a PharmD in this exploration of improving care in home and specialty infusion.

    Learning Objectives:

    1. Acquire ways to streamline documentation, drive accessibility to data, and expedite billing.
    2. Learn how omni-channel communication eases the administrative burden on staff, making them more effective, productive, and satisfied.
    3. Understand how integrating the right digital tools can improve your operational efficiency and seamlessly scale as your business grows.

    Melissa Kozak

    Co-Founder/CEO

    Citus Healthcare

    As a post-acute nurse, Melissa saw first-hand the communication and care coordination challenges connecting front line clinical teams with patients, field staff and partners in home-based care. She also recognized that providers were relying on manual processes to communicate and deliver care, causing inefficiencies and decreasing quality of care. Melissa teamed up with a leading healthcare technologist and founded CitusHealth in 2016 to tackle these challenges head on by providing real-time, secure solutions that ensure a high level of care team coordination and patient and family engagement.

    No Disclosures to Report

    Tanya Golovanoff

    Director

    Poudre Infusion Therapy

    Dr. Golovanoff’s road to a career in pharmacy began after receiving her Bachelor of Science in Molecular Biology from the University of Wyoming. She accepted admission to the Skaggs School of Pharmacy and Pharmaceutical Sciences at Colorado State University Anschutz Campus. While enrolled, she took her first pharmacy position in compounding with Cardinal Health Nuclear Pharmacy working as an intern for 4 years. After graduating with her Doctor of Pharmacy degree, she accepted a Pharmacy Manager position with a small nonsterile compounding pharmacy startup where she was able to further expand her non-sterile compounding knowledge. Dr. Golovanoff has dedicated the last seven years of her career to Poudre Infusion Therapy in Fort Collins Colorado where she currently serves as the Director. Poudre Infusion Therapy supplies infusion therapy services to their umbrella corporation, Columbine Health Systems. 

    No Disclosures to Report

  • Contains 4 Component(s), Includes Credits Recorded On: 11/09/2022

    The wait is over! With the release of USP General Chapter on November 1, 2022, sterile compounding organizations can finally move forward with implementing a higher standard of patient care.

    The wait is over! With the release of USP General Chapter <797> on November 1, 2022, sterile compounding organizations can finally move forward with implementing a higher standard of patient care. This webinar will highlight the major changes to USP General Chapter <797>, focusing on beyond-use dating, personnel training and competencies, viable sampling, and quality management. Nuance changes that significantly impact sterile compounding operations will also be discussed.

    Learning Objectives:

    1. Identifying the major chapter changes between the 2008 and 2022 version of USP <797>.
    2. Differentiate between Category 1, 2, and 3 compounded sterile preparations (CSPs) and list the specific requirements for each.
    3. Explain the requirements of the chapter defined competencies.
    4. List the required frequencies for viable air and surface sampling, based on the Category of CSPs compounded.
    5. Describe the components of an effective sterile compounding quality management system.

    Abby Roth, BS, CMQ/OE

    Founder

    Pure Microbiology

    Abby Roth, founder of Pure Microbiology, has over 18 years of experience in supporting the testing and consulting needs of the pharmaceutical, medical device, and compounding industries. Her background in pharmaceutical microbiology includes extensive knowledge of environmental monitoring. Abby served as a USP Compounding EC member during the 2015-2020 cycle. She is an involved member of the Controlled Environment Testing Association (CETA), serving on the Board of Directors, speaking at its annual meetings, and chairing committees for the revision of four CETA Application Guides. Abby has been invited to speak for state boards of pharmacy and for national organizations.

    No Disclosures to Report

  • Contains 2 Component(s) Recorded On: 10/05/2022

    This webinar will provide an understanding of the changes to Medicare policies for parenteral nutrition after three decades and the impact on home infusion.

    This webinar will provide an understanding of the changes to Medicare policies for parenteral nutrition after three decades and the impact on home infusion. New local coverage determinations for parenteral nutrition and the policy challenges that remain as well as advocacy efforts will be discussed. Kabicare Nutrition Resources created by Fresenius-Kabi, will be introduced as a tool to help home infusion practitioners navigate reimbursement challenges. 

    Learning Objectives:

    1. Describe advocacy efforts leading to the retirement of the previous obsolete Medicare policies for parenteral nutrition.
    2. Review new Local Coverage Determinations (LCDs) for parenteral nutrition.
    3. Understand the challenges the remain with the "new" policies and the impact on access to home nutrition support for Medicare beneficiaries.
    4. Introduce new Fresenius-Kabi resource to support reimbursement challenges in Parenteral Nutrition from Fresenius Kabi.
    5. Real-world application of how this resource will be useful in home infusion.

    Penny Allen, RD, CNSC

    National Director Nutrition Support

    Optum Infusion Pharmacy

    Penny Allen RD CNSC FASPEN FNHIAis the National Director, Nutrition Support for Optum Infusion Pharmacy. Pennybegan her nutrition support career at Beth Israel Hospital in Boston, Massachusettsafter obtaining her nutrition degree from the University of New Hampshire. Shehas spent over 30 years in the home infusion setting in a variety of roles,currently serving as a nutrition support program lead for Optum InfusionPharmacy. She is a Certified Nutrition Support Clinician (CNSC), serves asImmediate Past Chair of the ASPEN Public Policy Committee, current Chair of theNational Home Infusion’s Medicare Contractor and Advisory Committee and is apublished subject matter expert in Medicare PN and EN policies and other homenutrition support related topics. 

    No Disclosures to Report

    Tom Tsilipetros

    Sr Director of Market Access

    Fresenius Kabi

    Tom Tsilipetros is the SeniorDirector of Market Access at Fresenius Kabi, a global healthcare company thatspecializes in lifesaving medicines and technologies. Tom has over 20 years ofHealthcare and Pharma experience in a variety of R&D, Strategy, Marketing,Business Development, and Market Access roles with Baxter, AbbVie, Lundbeck, andFresenius Kabi. Tom received his Bachelor of Science degree in Chemistry fromLoyola University Chicago and his Master of Business Administration degree fromthe University of Chicago Booth School of Business. 

    No Disclosures to Report

  • Contains 2 Component(s) Recorded On: 09/21/2022

    Patient expectations are evolving, and the home infusion industry is challenged with elevating their solutions to meet these new demands.

    Patient expectations are evolving, and the home infusion industry is challenged with elevating their solutions to meet these new demands. But don’t worry, you can meet the demand for seamless, intuitive, digital experiences that will increase efficiency in the office and delight your patients. Join two home infusion pharmacists as they walk you through how a truly interactive digital experience can transform your day-to-day operations. 

    Learning Objectives:

    1. Why patients are expecting this elevated level of service and connection.
    2. How this will help you collect documents, completed forms, and digital signatures without spending valuable time making phone calls and leaving voicemails.
    3. How automation can save you time and always keep your patients informed with text messages automatically triggered throughout your workflow.

    Nupura Kolwalkar-Rana

    Chief Product Officer

    Brightree LLC

    Nupura Kolwalkar-Rana has extensive executive leadership experience in product strategy, new market penetration and data commercialization and is considered an expert in developing technologies that lead to positive health outcomes. She’s a firm believer that seamless coordination across all care is the key to patient adherence in the post-acute care setting; and, at Brightree, she focuses on putting product vision and patient experience front and center so that customers can deliver the best out-of-hospital care to their patients.

    No Disclosures to Report

  • Contains 4 Component(s), Includes Credits

    The prevalence of obesity has been steadily rising, increasing worldwide by 28% in adults between 1980 and 2013 with estimates that over one-third of adults in the U.S. can be classified as obese and as much as 50% of the U.S. population will be obese by 2030. For patients who fail to achieve or maintain goal weight loss withother interventions, particularly those with a BMI of ≥40 kg/m2 or a BMI of 35-39.9 kg/m2 with 1 serious comorbidity, bariatric surgery (BS) is an option.

    The prevalence of obesity has been steadily rising, increasing worldwide by 28% in adults between 1980 and 2013 with estimates that over one-third of adults in the U.S. can be classified as obese and as much as 50% of the U.S. population will be obese by 2030. For patients who fail to achieve or maintain goal weight loss withother interventions, particularly those with a BMI of ≥40 kg/m2 or a BMI of 35-39.9 kg/m2 with 1 serious comorbidity, bariatric surgery (BS) is an option. But, these procedures can result in complications that require nutrition support until they are resolved. This article reviews the different surgical procedures and how they effect weight loss, as well as possible complications and how these might compromise nutritional status. Indications for nutrition support following BS are reviewed in additional to patient assessment and considerations for building a care plan. 

    Learning Objectives:

    1. Differentiate between the different bariatric surgical procedures and how each works to effect weight loss.
    2. Understand the possible complications associated with bariatric surgical procedures and how they may affect a patient's ability to take in and/or obsorb nutrients.
    3. List the conditions under which it is appropriate to consider parenteral nutrition (PN) in bariatric surgery patients.
    4. List 3 considerations for clinicians when creating a PN care plan for post-bariatric surgical patients.

    Nicole Goben, MS, RD, CDN, CNSC

    Clinical Dietitian

    Yale New Haven Hospital

    Nicole Goben, MS, RD, CDN, CNSC is an inpatient Clinical Dietitian at Yale New Haven Hospital. She has been a Registered Dietitian for 8 years and a certified nutrition support clinician for 2 years. She started her nutrition career in Buffalo, New York in the community sector but found her passion in clinical nutrition and nutrition support. She has vast experience working with post bariatric surgery patients who have required PN both inpatient and at home.

     

    No Disclosures to Report

    Katie Laskin, PharmD, BCSCP, CNSC

    Clinical Pharmacist

    Yale New Haven Home Infusion

    Katie Laskin, PharmD, BCSCP, CNSC is a Clinical Pharmacist with Yale New Haven Health's Home Infusion program. She received her PharmD from the University of Connecticut in 2005 and has been working in home infusion in various roles since 2006. She is a Board Certified Sterile Compiunding Pharmacist and a Certified Nutrition Support Clinician.

    No Disclosures to Report

  • Contains 2 Component(s) Recorded On: 08/31/2022

    ​Join our panel of industry leaders for this forward-looking discussion on the fascinating implications of the broad-reaching Inflation Reduction Act (IRA) on the home and alternate site infusion industry.

    Join our panel of industry leaders for this forward-looking discussion on the fascinating implications of the broad-reaching Inflation Reduction Act (IRA) on the home and alternate site infusion industry.

    Relevant provisions in the IRA include:

    • $2,000/year cap on patient out-of-pocket costs for Medicare Part D drugs, beginning in 2025 
    • Medicare can negotiate the price of prescription drugs with manufacturers, beginning with 10 drugs in 2026, expanding by 15 drugs in 2027 and 2028, and expanding again by 20 drugs in 2029--for a total of 60 drugs by 2029
    • Pharmaceutical companies will be required to issue an “inflation rebate” for Medicare drugs whose prices they set higher than the rate of inflation. A similar provision for drugs covered under commercial insurance failed.

    Panelists will include:

    • Connie Sullivan, NHIA President and CEO
    • Logan Davis, Vice President of Trade, Vital Care Inc
    • Jayson Slotnick, Partner, Health Policy Strategies
    • Jennifer Snow, Vice President of Market Economics, AmerisourceBergen

    We will also provide a brief update on the status and timeline for the Preserving Patient Access to Home Infusion Act.

    Talk Infusion 2022 Webinar Series Sponsored by McKesson.

    Connie Sullivan

    President & CEO

    National Home Infusion Association

    Connie Sullivan, BSPharm, is the President and CEO of NHIA. Prior to joining the NHIA staff, Sullivan was a practicing home infusion pharmacist and National Infusion Director for HCR ManorCare for 15 years. She is the Vice Chair of USP’s Sterile Compounding Expert Committee and USP’s Parenteral Nutrition Safety Expert Panel.

    No Disclosures to Report

    Logan Davis

    VP of Trade

    Vital Care Infusion Services

    Logan is a pharmacist and Director of Trade and Business Development with Vital Care Infusion Services, a national infusion pharmacy franchise organization based in Meridian, Mississippi.  Vital Care’s growing network of franchisees provide infusion services in multiple sites of care including home infusion, infusion suites, and infusion clinics.  In his role he leads a team responsible for trade contracting and business development. He is a co-owner of multiple Vital Care franchises, and serves on the Board of Directors for the National Home Infusion Association.

    No Disclosures to Report

    Jayson Slotnick

    Partner

    Health Policy Strategies

    No Disclosures to Report

    Jennifer Snow

    VP of Market Economics

    AmerisourceBergen

    No Disclosures to Report

  • Contains 4 Component(s), Includes Credits Recorded On: 08/31/2022

    Join Dr Valerie Amarosa for a discussion on the latest in the therapeutic landscape for COVID-19. This program will take a deep dive into the current state of the virus, variants, and what a future with COVID-19 looks like.

    Join Dr Valerie Amarosa for a discussion on the latest in the therapeutic landscape for COVID-19. This program will take a deep dive into the current state of the virus, variants, and what a future with COVID-19 looks like. We will also discuss the current therapeutic and vaccine options for treatment and prevention. We will end with a discussion of the major impacts and changes for the home and alternate sire infusion industry as a result of the COVID-19 pandemic.

    Learning Objectives

    1. Explain the current landscape with regard to COVID-19, variants, and what the future holds.
    2. Discuss the current treatment options for COVID-19 in the home and alternate site industry.
    3. Review the current vaccine options and best practices for patient populations.
    4. Explain the major impacts and changes on the home and alternate site industry as a result of COVID-19.

    Dr Valerianna Amorosa

    Medical Director

    Penn Home Infusion

    Dr. Valerianna Amorosa, MD is the Medical Director for Penn Home Infusion Therapy. She received her BA in Molecular Biology from Princeton University and her Medical Degree from Washington University in St. Louis. Her areas of expertise infectious disease, clinical research in HIV, HCV coinfection, and medical education with over 22 years of experience in practice. She is currently a Professor of Clinical Medicine at the Perelman School of Medicine at the University of Pennsylvania.

    No Disclosures to Report